Key clinical point: Topical calcineurin inhibitors (TCIs) are a treatment option for pediatric periorificial dermatitis (POD).
Major finding: The researchers observed complete response in 65% of patients treated with TCI alone.
Study details: A retrospective cohort study of 132 pediatric patients with POD.
Disclosures: The researchers reported having no financial disclosures.
Ollech A et al. SPD 2019, poster 23.